NRX Pharmaceuticals
NRXP
NRXP
25 hedge funds and large institutions have $9.76M invested in NRX Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 2 closing their positions.
Holders
25
Holders Change
+3
Holders Change %
+13.64%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
10
Reduced
4
Closed
2
Calls
$145K
Puts
$18K
Net Calls
+$127K
Net Calls Change
-$177K
Top Buyers
| 1 |
AFM
1
Anson Funds Management
Dallas,
Texas
|
$5.23M |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$396K |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$301K |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$1.47M |
| 5 |
5
Squarepoint
New York
|
$138K |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TC
26
TownSquare Capital
Provo,
Utah
| – | – | -15,041 | Closed |
|
27
Fidelity Investments
Boston,
Massachusetts
| – | – | -37 | Closed |
|